World Journal of
Pharmaceutical and Life Sciences

CORONA VIRUS - A REVIEW OF COVID-19

*Richa Arora and Neha Rastogi

ABSTRACT

An acute respiratory disease, caused by a novel Coronavirus (SARS- COV2), previously known as 2019 – nCOV), the coronavirus disease 2019 (COVID-19) is highly transmittable and pathogenic viral infection, has spread throughout china and received worldwide attention. On 30th January 2020, WHO officially declared the COVID-19 epidemic as a public health emergency of international concerns. The emergency of SARS -CoV2, since the severe acute respiratory syndrome coronavirus (SARS-COV) in 2002 and (MERS-COV) in 2012 marked the third introduction of a highly pathogenic and large-scale epidemic into human population in Twenty first century. As of 1st March 2020, a total of 87,137 confirmed case globally and 79,968 confirmed cases in china with 2,977 deaths (3.4%) had been reported by WHO. Increasingly evidence showed sustained human to human transmission along with many exported cases across the globe. The clinical symptoms of COVID-19 patients include fever, dry cough, fatigue and respiratory infection. The elderly and the small children under 10 years and people with underlying diseases are susceptible to infection and prone to serious outcome, which may be associated with Acute Respiratory Distress Syndrome (ARDS). In this review we summarized the latest research progress of the epidemiology, pathogenesis and clinical characteristics of Covid-19 and discuss the current treatment and scientific advancement to combat the epidemic novel coronavirus.

[Full Text Article]   [Download Certificate]